Mitral and tricuspid annular velocities determined by Doppler tissue imaging in hypopituitary, growth hormone-deficient patients

Hormone Research

Volumn 64, Issue 3, 2005, Pages 107-114

  Yurci, Alper ^a   Oflaz, Huseyin ^a   Meric, Mehmet ^a   Ozbey, Nese ^b,c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Atherosclerosis; Diastolic dysfunction; Growth hormone deficiency; Hypopituitarism; Tissue Doppler imaging

Indexed keywords

GROWTH HORMONE;

ADULT; AGE DISTRIBUTION; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; CALCULATION; CLINICAL ARTICLE; COMMON CAROTID ARTERY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; DOPPLER FLOWMETRY; DRUG DOSE REGIMEN; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOPITUITARISM; INTIMA; LONG TERM CARE; MALE; MITRAL VALVE; MULTIPLE REGRESSION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SUBSTITUTION THERAPY; THICKNESS; TRICUSPID VALVE;

ADULT; AGING; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; MALE; MIDDLE AGED; MITRAL VALVE; REGRESSION ANALYSIS; SYSTOLE; TRICUSPID VALVE; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 27144455807     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088336     Document Type: Article

References (39)

1. Rosen T, Bengtsson B-A: Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336:285-288.
2. Bates AS, Hoff WV, Jones PJ, Clayton RN: The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 1996;81:1169-1172.
3. Bülow B, Hagmar L, Mikoczy Z, Nordström C-H, Erfurth EM: Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol 1997;46:75-81.
4. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM: Association between premature mortality and hypopituitarism. Lancet 2001;357:425-431.
5. Stavrou S, Kleinberg DL: Diagnosis and management of GH deficiency in adults. Endocrinol Metab Clin North Am 2001;30:545-563.
6. Markussis V, Besyah SA, Fischer C, Sharp P, Nicolaides AN, Johnston DG: Detection of premature atherosclerosis by high resolution ultrasonography in symptom free hypopituitary adults. Lancet 1992;340:1188-1192.
7. Capaldo B, Patti L, Oliviero U, Longobardi S, Pardo F, Vitale F, Fazio S, DiRella F, Biondi B, Lombardi G, Sacca L: Increased arterial intima media thickness in childhood onset growth hormone deficiency. J Clin Endocrinol Metab 1997;82:1373-1381.
8. Markussis V, Beshyah SA, Fischer C, Parker K, Nicolaides AN, Johnston DG: Abnormal carotid artery wall dynamics in symptom free hypopituitary adults. Eur J Endocrinol 1997;136:157-164.
9. Grobbe DE, Bots ML: Carotid artery intimamedia thickness as an indicator of generalized atherosclerosis. J Intern Med 1994;235:431-433.
10. Crouse JR 3rd, Craven TE, Hagaman AP, Bond MG: Associations of coronary disease with segment specific intimal-medial thickening of the extracranial carotid artery. Circulation 1995;92:1141-1147.
11. Amato G, Carella C, Fazio S, LaMontagna G, Cittadini A, Sabatini D, Marciano-Mone C, Sacca L, Bellastella A: Body composition, bone metabolism and heart structure and function in growth hormone deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab 1993;77:1671-1676.
12. Merola B, Cittadini A, Colao A, Longobardi S; Fazio S, Sabatini D, Sacca L, Lombardi G: Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab 1993;77:1658-1661.
13. Frustaci A, Perrone GA, Gentiloni N, Russo MA: Reversible dilated cardiomyopathy due to growth hormone deficiency. Am J Clin Pathol 1992;97:503-511.
14. Fazio S, Biondi B, Sabatini D, Cuocolo A, Tommaselli AP, Lombardi G, Sacca L: Long-term growth hormone deficiency as a cause of cardiomyopathy and its reversibility with specific replacement therapy. J Clin Endocrinol Metab 1996;81:887-890.
15. Shahi M, Beshyah SA, Hackett D, Sharp PS, Johnston DG, Foale RA: Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality. Br Heart J 1992;67:92-96.
16. Ozbey N, Sezgil A, Oflaz H, Umman B, Orhan Y, Sencer E, Molvalilar S: Left ventricular diastolic function abnormalities in hypopituitary patients with GH deficiency: Evidence for a subclinical cardiomyopathy. J Endocrinol Invest 2002;25:590-597.
17. Alam M, Wardell J, Anderson E, Samad BA, Nordlander R: Characteristics of mitral and tricuspid annular velocities determined by pulsed wave Doppler tissue imaging in healthy subjects. JAm Soc Echocardiogr 1999;12:618-628.
18. Farias CA, Rodriguez L, Garcia MJ, Sun JP, Klein AL, Thomas JD: Assessment of diastolic function by tissue Doppler echocardiography: comparison with standard transmitral and pulmonary venous blood flow. J Am Soc Echocardiogr 1999;12:609-617.
19. Caso P, D'Andrea A, Galderisi M, Liccardo B, Severino S, DeSimone L, Izzo A, D'Andrea L, Mininni N: Pulsed Doppler tissue imaging in endurance athletes: relation between left ventricular preload and myocardial regional diastolic function. Am J Cardiol 2000;85:1131-1136.
20. Alam M, Wardell J, Anderson E, Samad BA, Nordlander R: Effects of first myocardial infarction on left ventricular systolic and diastolic function with the use of mitral annular velocity determined by pulsed wave Doppler tissue imaging. J Am Soc Echocardiogr 2000;13:343-352.
21. Herrmann BL, Saller BB, Bartel T, Ferdin S, Erbel R, Mann K: Acromegaly: evidence for a direct relation between disease activity and cardiac dysfunction in patients without ventricular hypertrophy. Clin Endocrinol 2002;56:595-602.
22. Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ, HypoCCS Advisory Board, US HypoCCS Study Group: Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab 2002;87:477-485.
23. Gomez JM, Espadero RM, Escobar-Jimenez F, Hawkins F, Pico A, Herrera Pombo JL, Vilardell E, Duran A, Mesa J, Faure E, Sanmarti A: Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults. Clin Endocrinol 2002;56:329-334.
24. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA: Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-1533.
25. Roupas P, Chou SY, Towns RJ, Kostyo JL: Growth hormone inhibits activation of phosphatidylinositol phospholipase C in adipose plasma membranes: evidence for a growth hormone-induced change in G protein function. Proc Natl Acad Sci USA 1991;88:1691-1695.
26. Pieroni M, Chimenti C, Ricci R, Sale P, Russo MA, Frustaci A: Early detection of Fabry cardiomyopathy by tissue Doppler imaging. Circulation 2003;107:1978-1984.
27. Chetboul V, Escriou C, Tessier D, Richard V, Pouchelon JL, Thibault H, Lallemand F, Thuillez C, Blot S, Derumeaux G: Tissue Doppler imaging detects early asymptomatic myocardial abnormalities in a dog model of Duchenne's cardiomyopathy. Eur Heart J 2004;25:1934-1939.
28. Vinereanu D, Bajaj BPS, Fenton-May J, Rogers MT, Madler CF, Fraser AG: Subclinical cardiac involvement in myotonic dystrophy manifesting as decreased myocardial Doppler velocities. Neuromuscul Disord 2004;14:188-194.
29. Watts GF, Marvick TH: Ventricular dysfunction in early diabetic heart disease: detection, mechanisms and significance. Clin Sci 2003;105:537-540.
30. Peterson LR, Waggoner AD, Schechtman KB, Meyer T, Gropler RJ, Barzilai B, Davila-Roman BG: Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol 2004;43:1399-1404.
31. Davani EY, Brumme Z, Singhera GK, Cote HC, Harrigan PR, Dorscheid DR: Insulin-like growth factor-1 protects ischemic murine myocardium from ischemia/reperfusion associated injury. Crit Care 2003;7:R176-R183.
32. Norby FL, Aberle NS 2nd, Kajstura J, Anversa P, Ren J: Transgenic over-expression of insulin-like growth factor I prevents streptozotocin-induced cardiac contractile dysfunction and beta-adrenergic response in ventricular myocytes. J Endocrinol 2004;180:175-182.
33. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, Kajstura J, Baserga R, Anversa P: Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, cardiac hypertrophy. J Clin Invest 1997;100:1991-1999.
34. Sesmilo G, Miller KK, Hayden D, Klibanski A: Inflammatory cardiovascular risk markers in women with hypopituitarism. J Clin Endocrinol Metab 2001;86:5774-5781.
35. Carroll PV, Christ ER, Bengtsson B-A, Carlsson L, Christiansen JS, Clemmonds D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, Thorne M: Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J Clin Endocrinol Metab 1998;83:382-395.
36. Besyah SA, Johnston DG: Cardiovascular disease risk and risk factors in adults with hypopituitarism. Clin Endocrinol 1999;50:1-15.
37. Rosen T, Eden S, Larson G, Wilhelmsen S, Bengtsson BA: Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol 1993;129:125-200.
38. Ozbey N, Algun E, Turgut AS, Orhan Y, Sencer E, Molvalilar S: Serum lipid and leptin concentrations in hypopituitary patients with growth hormone deficiency. Int J Obesity 2000;24:619-626.
39. Dandel M, Wellnhofer E, Hummel M, Meyer R, Lehmkuhl H, Hetzer R: Early detection of left ventricular dysfunction related to transplant coronary artery disease. J Heart Lung Transplant 2003;22:1353-1364.